These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 31823615)
1. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells. Long Y; Lu Z; Xu S; Li M; Wang X; Zhang Z; He Q Nano Lett; 2020 Apr; 20(4):2219-2229. PubMed ID: 31823615 [TBL] [Abstract][Full Text] [Related]
2. Micellar nanoparticles inhibit breast cancer and pulmonary metastasis by modulating the recruitment and depletion of myeloid-derived suppressor cells. Lu Z; Liu H; Ma L; Ren K; He Z; Li M; He Q Nanoscale; 2022 Dec; 14(46):17315-17330. PubMed ID: 36374496 [TBL] [Abstract][Full Text] [Related]
3. Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression. Lu Z; Long Y; Wang Y; Wang X; Xia C; Li M; Zhang Z; He Q Eur J Pharm Biopharm; 2021 Aug; 165():164-173. PubMed ID: 34020022 [TBL] [Abstract][Full Text] [Related]
4. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression. Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671 [TBL] [Abstract][Full Text] [Related]
5. Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-κB pathway and promoting MDSCs depletion. Lu Z; Ma L; Mei L; Ren K; Li M; Zhang L; Liu X; He Q Int J Pharm; 2022 Nov; 628():122303. PubMed ID: 36265660 [TBL] [Abstract][Full Text] [Related]
6. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche. Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937 [TBL] [Abstract][Full Text] [Related]
7. Metformin and Docosahexaenoic Acid Hybrid Micelles for Premetastatic Niche Modulation and Tumor Metastasis Suppression. Jiang T; Chen L; Huang Y; Wang J; Xu M; Zhou S; Gu X; Chen Y; Liang K; Pei Y; Song Q; Liu S; Ma F; Lu H; Gao X; Chen J Nano Lett; 2019 Jun; 19(6):3548-3562. PubMed ID: 31026397 [TBL] [Abstract][Full Text] [Related]
8. Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression. Zhang J; Han X; Shi H; Gao Y; Qiao X; Li H; Wei M; Zeng X Mol Cell Probes; 2020 Apr; 50():101498. PubMed ID: 31891749 [TBL] [Abstract][Full Text] [Related]
9. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475 [TBL] [Abstract][Full Text] [Related]
10. Xiaoliu Pingyi Pecipe Inhibits Lung Pre-Metastatic Niche Formation and Prevents Myeloid-Derived Suppressor Cells Recruitment. Li H; Yang F; Zhang L; Zhao R; Li X; Li H Integr Cancer Ther; 2023; 22():15347354231187000. PubMed ID: 37431869 [TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
12. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells. Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Melanoma-Targeted Therapy by "Fru-Blocked" Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles. Long Y; Lu Z; Mei L; Li M; Ren K; Wang X; Tang J; Zhang Z; He Q Adv Sci (Weinh); 2018 Nov; 5(11):1800229. PubMed ID: 30479911 [TBL] [Abstract][Full Text] [Related]
14. Bioresponsive Nanoparticles Boost Starvation Therapy and Prevent Premetastatic Niche Formation for Pulmonary Metastasis Treatment. Xing Y; Zhang Y; Li J; Tang Y; Zhang J; Yang R; Tang H; Qian H; Huang D; Chen W; Zhong Y ACS Appl Mater Interfaces; 2024 Oct; 16(39):51798-51806. PubMed ID: 39301793 [TBL] [Abstract][Full Text] [Related]
15. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466 [TBL] [Abstract][Full Text] [Related]
16. Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection. Tang F; Tie Y; Hong W; Wei Y; Tu C; Wei X Ann Surg Oncol; 2021 Jul; 28(7):4030-4048. PubMed ID: 33258011 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis. Kang T; Zhu Q; Wei D; Feng J; Yao J; Jiang T; Song Q; Wei X; Chen H; Gao X; Chen J ACS Nano; 2017 Feb; 11(2):1397-1411. PubMed ID: 28075552 [TBL] [Abstract][Full Text] [Related]
18. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
19. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Jian J; Pang Y; Yan HH; Min Y; Achyut BR; Hollander MC; Lin PC; Liang X; Yang L Oncotarget; 2017 Apr; 8(17):27725-27739. PubMed ID: 27223426 [TBL] [Abstract][Full Text] [Related]